Biologics among fastest growers












The U.S. pharmaceutical market was $211 billion in 2003, the first time the market exceeded $200 billion. Roughly $22 billion of that market was biotech products, according to IMS Health. The strongest growth was seen in the generic and biologic sectors. Managed care plans and pharmacy benefit managers can benefit from the strong generic presence in the market, but also face challenges relating to biotech drugs.

Dollar growth in sales

September 2002–September 2003

SOURCE: RETAIL AND PROVIDER PERSPECTIVE, IMS HEALTH, PLYMOUTH MEETING, PA, 2003

Career Opportunities

HAP, a subsidiary of Henry Ford Health System, is a nonprofit health plan providing coverage to individuals, companies and organizations. This executive develops strategies to meet membership and revenue targets through products, pricing, market segmentation and advertising.  Aligns business among Business Development, Commercial Sales, Medicare and Public Sector Programs and Product Development. Seeks to enhance and be responsible for business development and expansion through the development of an effective product portfolio, strong interpersonal relationships and service excellence.

Apply via email to jfedder1@hfhs.org or online at http://p.rfer.us/HENRYFORDlXqAJA

Subscribe to Our Newsletters

Monthly table of contents

Be notified as each issue of Managed Care is available online.

Biweekly newsletter

Recent topics have included:

PTCommunity news

New drug approvals, clinical trials, drug management. Three times per week.